- Home
- ABEV vs IQV Comparison
ABEV vs IQV Comparison
Compare ABEV & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEV
- IQV
- Stock Information
- Founded
- ABEV 1885
- IQV 1982
- Country
- ABEV Brazil
- IQV United States
- Employees
- ABEV N/A
- IQV N/A
- Industry
- ABEV Beverages (Production/Distribution)
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ABEV Consumer Staples
- IQV Health Care
- Exchange
- ABEV Nasdaq
- IQV Nasdaq
- Market Cap
- ABEV 33.8B
- IQV 37.2B
- IPO Year
- ABEV N/A
- IQV 2013
- Fundamental
- Price
- ABEV $2.18
- IQV $217.83
- Analyst Decision
- ABEV Hold
- IQV Strong Buy
- Analyst Count
- ABEV 4
- IQV 20
- Target Price
- ABEV $2.35
- IQV $242.10
- AVG Volume (30 Days)
- ABEV 47.1M
- IQV 1.8M
- Earning Date
- ABEV 10-30-2025
- IQV 10-28-2025
- Dividend Yield
- ABEV 7.90%
- IQV N/A
- EPS Growth
- ABEV 2.96
- IQV N/A
- EPS
- ABEV 0.17
- IQV 7.30
- Revenue
- ABEV $16,833,014,419.00
- IQV $15,904,000,000.00
- Revenue This Year
- ABEV $5.86
- IQV $6.01
- Revenue Next Year
- ABEV $4.97
- IQV $4.87
- P/E Ratio
- ABEV $12.96
- IQV $29.83
- Revenue Growth
- ABEV 13.76
- IQV 3.85
- 52 Week Low
- ABEV $1.76
- IQV $134.65
- 52 Week High
- ABEV $2.64
- IQV $225.91
- Technical
- Relative Strength Index (RSI)
- ABEV 44.84
- IQV 66.37
- Support Level
- ABEV $2.10
- IQV $209.46
- Resistance Level
- ABEV $2.25
- IQV $225.00
- Average True Range (ATR)
- ABEV 0.05
- IQV 6.41
- MACD
- ABEV 0.00
- IQV 0.58
- Stochastic Oscillator
- ABEV 42.11
- IQV 73.69
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.